Introduction
Despite recent advances in molecular technology and therapeutics, the prognosis of patients suffering from malignant brain tumor has not changed over the past 20 years. Gene expression profiling has emerged as a novel tool for rapid discovery of molecular expression patterns associated with human disease (Alizadeh et al., 2000; Alter et al., 2000; Bittner et al., 2001; Golub et al., 1999) . Furthermore, the completion of the human genome project has created the possibility of studying changes in gene expression of the complete genetic repertoire in any disease-affected tissue. However, genome-wide screening is still hampered by the preponderance of false positive data in the gene microarray experimental system (Ting Lee et al., 2000) .
The following experiments are designed to profile the expression of 19 200 cDNAs in 35 human glioma samples. Here, we apply mathematical principles to separate the noise and extract genes whose expression levels are considered truly changed, to a high degree of confidence, in the tumor samples as compared to normal brain. The results yield a genetic analysis of gliomas, identify genes whose expression patterns differentiate glioblastoma from lower-grade tumors and radiation necrosis, and discover classes of genetic expression that link novel genes to the biology of gliomas.
Results and discussion
The experiments are designed to generate four replicate ratios with probe switching. The replicate data are averaged and expressed in a matrix containing 19 200 gene rows and 35 tumor columns; the overwhelming majority of the standard deviations of the replicate 'prepared' data are less than 1. The tumor vectors are analysed using current standard techniques by: (1) omitting gene vectors excluded (see Methods) in more than 20% of the tumor set; 18 314 rows remain. (2) Agglomerative hierarchical clustering using single linkage of Ward's incremental sum of squares of the 1-Pearson product moment correlation matrix (Everitt, 1993) . The resulting dendrogram does not distinguish between the different pathological types. The results are not surprising because only a fraction of the 18 314 genes is expected to be modulated in brain tumors. The findings, suggesting that noise vectors mask the pathological distinction, highlight the need for new methods to separate true from false measurements.
To study and model the noise in this experimental system we define the filtering function f 4 (applied to four replicate ratio measurements). f 4 computes the mean of the four replicate log2 values only if: (1) all four log2 values are of the same sign and different than 0; (2) all four replicate ratios are either 50.71 or 41.4; and (3) a minimum of three spots are not flagged manually because of artifacts. If all three conditions are not met, f 4 'filters' the gene by assigning a 0 to the log2 expression value.
The next experiment is designed to study whether f 4 generates false negative data. Here we use microarray chips containing 1720 genes laid in duplicates (1.7 K chips from the Ontario Cancer Institute, Toronto, Canada). Each 1.7 K chip contains a total of 128 spots of Arabidopsis cDNA with no known homology to human genes (64 laid in duplicates) and 256 spots of buffer only (SSC). One ng of Arabidopsis RNA transcribed in vitro are added to tumor RNA and either: (1) not added, or (2) 0.5 ng added to reference RNA. Each of these experiments are repeated six times to a total of 12 spots. The results reveal that, after applying f 4 to four replicate spots, 1.6% of the Arabidopsis spots are false negative, and 0 -2% of the SSC spots without cDNA are false positive (Figure 1 ). Thus, f 4 annuls false positive results without significant loss of data reflecting true changes in gene expression.
Mathematical modeling of noise
Because the predominant majority (495%) of the data zeroed by f 4 (applying the filtering function to four replicate measurements) are false (see Figure 1 ) and because the expression of only a small fraction of the genes is expected to be truly changed, we reasoned that by separating unfiltered false positive data, one could use them to model the behavior of noise ( Figure  2 ). To generate 'noise' matrices containing false positive data, the unfiltered log2 values of the replicate ratios are expressed in four matrices E 11 , E 12 , E 13 , E 14 of size (19 200635) , each corresponding to one of the four replicate spots. The rows and columns refer to the 19 200 genes and 35 tumors, respectively. The filtered data after application of f 4 are assembled to generate a matrix E of size (19 200635) its rows correspond to the 19 200 genes and columns to the 35 tumor samples: 9155 genes of E have log2 values=0 in all 35 tumor columns. The 'noise' matrices N 1 , N 2 , N 3 and N 4 are constructed to contain the unfiltered expression data of the 9155 genes mentioned above in E 11 , E 12 , E 13 and E 14 , respectively (Figure 2) .
We model the noise by projecting the gene vectors onto spaces defined by linear transformation of their matrices. Singular value decomposition is a mathematical application that transforms the rows of a matrix into vectors in space (eigenspace). The dimension of the eigenspace equals the number of entries in each row; here the 35-dimensional space (Figure 2 ). Transformation by singular value decom- Figure 1 f 4 filters false positive data without significant loss of true changes in gene expression. One ng of Arabidopsis RNA transcribed in vitro are added to tumor RNA and either: (1) not added (dotted lines), or (2) 0.5 ng added to the reference RNA (solid lines). The curves on the right show per cent false negative Arabidopsis spots after applications of the filtering functions (supplementary information) to the measurements of two spots (1,2), . . ., four spots (1,2,3,4), . . ., and 12 spots (1 -12), respectively. Per cent false negative refers to the number of Arabidopsis spots whose expression values are equal to 0 after application of the filtering functions* 100/total number of Arabidopsis spots. The curves on the left show per cent false positive SSC (buffer) spots; the latter refers to the number of buffer spots whose measured expression values are different than 0 after application of the filtering function* 100/total number of buffer spots. The per cent false negative values are 1.6% at four and six spots, 5 -6% at eight spots, and 9 -11% at 12 spots Figure 2 Cartoon depicting the assembly of 'noise' matrices. The four replicate data are assembled into four matrices E 11 , E 12 , E 13 and E 14 , each corresponding to one of the four groups of measurements; their rows correspond to the 19 200 genes and columns to the 35 tumors. The filtering function f 4 is applied to the four replicate measurements of each gene located at the same coordinates in each matrix (stars). f 4 generates the matrix E. 9155 gene vectors of E have log2 values=0 in all tumor columns. The noise matrices N 1 , N 2 , N 3 and N 4 are constructed to contain the unfiltered data of the 9155 genes in E 11 , E 12 , E 13 and E 14 respectively position generates three matrices (supplementary information); one defines the 'axes' of the space (eigenvectors); another includes numbers related to the coordinates of the row vectors onto each axis; and the third contains a quantification of how much information is lost if the eigenspace is reduced to a lower 'manageable' dimensionality, like the 3-dimensional space. Nonetheless, if reducing dimensionality wastes large amounts of information, projecting onto the 3-dimensional space (principal component analysis) does not generate a reliable representation of the vectors in the 35-dimensional space. In this case, studying the geometrical representation in the 35-dimensional space becomes necessary. Plotting the 3-dimensional projections onto the space defined by the first three eigenvectors (principal components) reveals that the noise vectors fall within a sphere around the origin (Figure 3a) . However, these 3-dimensional subspaces capture only 13.3, 13.4, 11.9 and 11.9% of the information in N r , 14r44 respectively ( Figure 3b ). To capture all the information, the gene vectors of N r are thus projected onto the corresponding 35-dimensional space defined by all their eigenvectors. Plotting the distances from the origin (eigendistances) in the 35-dimensional space reveals that the gene row vectors of N r also project within a spherical structure (Figure 3c ). In addition, histograms of the projections (eigenprojections) of the row vectors of N 1 , N 2 , N 3 , and N 4 onto the 35-dimensional spaces show that the distances from the origin follow normal distributions of means=3.9, 3.9, 3.8, 3.8 and standard deviations=1.2, respectively (Figures 4a, b) .
Separation of noise and extraction of true measurements
Eigenprojections of the gene row vectors of E 11 , E 12 , E 13 , E 14 onto their corresponding 35-dimensional spaces result in eigendistances that follow normal distributions of means=4, 4, 3.9, 3.9, and standard deviations=1.4, 1.4, 1.3, 1.3; respectively (Figures 4a,  b) . The results demonstrate that the distributions of the noise matrices N r overlap the distribution of the data matrices E 1r , 14r44. This is not surprising because the idea of normalization stipulates that the expression measurements of the predominant majority of the genes do not differ between sample and reference. Because N r and E 1r have similar distributions, the mean and standard deviations of the latter are used to find the confidence interval about the mean that includes the overwhelming majority of the vectors of N r . The eigendistance that excludes all the noise vectors in E 11 is 8.3, which corresponds to a confidence level of 99.8% (three standard deviations from the mean). The 99.8% confidence levels of E 12 , E 13 , E 14, exclude all the row vectors of the noise matrices N 2 , N 3 and N 4 except 1. The results demonstrate that: (1) the 99.8% confidence interval includes the overwhelming majority of the projections of the vectors of N 1 , N 2 , N 3 and N 4 and; (2) the distributions of the projections the vectors of E 11 , E 12 , E 13 , E 14 overlap the distribution of noise, thus necessitating filtering. Figure 3 The gene vectors of the four noise matrices N r , 14r44 project within spherical structures in the 3-and 35-dimensional eigengene spaces. (a) A plot of the eigenprojections of the row vectors of N 1 (red), N 2 (blue), N 3 (green), and N 4 (cyan) onto the subspaces defined by their corresponding first three eigengenes. The eigenprojections fall within a sphere around the origin. Let ev j denote the eigenvalue corresponding the jth eigengene, 14 j435. The expression fraction (EFj) of the jth eigengene is defined as:
EFj reflect the 'amount of information' carried by the corresponding eigengenes. The first three eigengenes capture 13.3, 13.4, 11.9, and 11.9% of information in N 1 (b), N 2 , N 3 and N 4 , respectively. Nonetheless, projecting the row vectors of N r, 14r44, onto their corresponding 35-dimensional eigen spaces reproduces the spherical structure seen in the 3-dimensional space (a and c)
Hence, we apply two filters; the first is the function f 4 . The matrix E contains the means of the expression data in E 11 , E 12 , E 13 , E 14 , after application of the filter f 4 (Figure 2 ). Figure 4a shows that 9155 gene vectors=0 of E project at the origin; these correspond to the same genes whose unfiltered data make up the noise matrices. The predominant majority of the 10 045 vectors of E that are different than 0 are expected to be false. The eigendistance from the origin in the 35-dimensional space of an expression row vector V(v 1 ,. . .,v 35 ) is also equal to its norm (
). Thus, by zeroing false positive coordinates, the f 4 filter preferentially shifts the distribution of the noise vectors closer to 0. Specifically, because true vectors contain fewer false positive coordinates than noise, the f 4 filter is expected to lower their norms much less than noise vectors (Figure 4a , arrows). Therefore, the matrix E encompasses a sharper separation of true from false than E 11 , E 12 , E 13 , or E 14 . As anticipated, a histogram plot of the norms of the expression vectors of E (rows) shows shifting of the normal distribution of the noise vectors closer to the origin (Figures 4a,  c) ; mean=1.9 and standard deviation=1.3.
The second filter is applied to exclude the row vectors of E whose norms fall within the 99.8% confidence interval. The norms of 108 gene vectors of E are 45.9, a distance that corresponds to a minimum confidence level 499.8% (three standard deviations from the mean). The matrices in Figure  5a ,b assemble the 108 gene vectors resistant to the application of both filters. The matrix C (Figure 5a ) contains the 92 genes whose replicate ratio measurements are not filtered by f 4 in at least 30% of the tumor set. The gene (row) vectors of C are ordered following their grouping by agglomerative hierarchical clustering using single linkage. The remaining 16 genes are shown in Figure 5b .
Molecular classification and coefficients of variance
To address the question whether the extracted genetic information replicates the pathological distinction, the 35 tumor (column) vectors are grouped by agglomerative hierarchical clustering using Ward's incremental sum of squares of the 1-Pearson product moment correlation matrix. The dendrogram reveals that glioblastoma multiforme (GBM) samples cluster together separate from lower grade tumors. Interestingly, four high-grade glioma samples that clustered with lower grade tumors showed pathological changes consistent with radiation necrosis (Figure 5c ). Figure 5d shows the results of clustering the tumors vectors by the distances that separate their projections in the eigentumor space; the dendrogram is similar to Figure 5c ; thus presenting evidence of geometrical clustering of the tumors. The fact that the molecular classification replicates the pathological classification lends additional support to the validity of the extracted expression measurements, especially because the clustering methods do not consider any clinical information.
The coefficients of variance are computed to study the variance among the expression values of the four unfiltered replicate data corresponding to the elements of C (Figures 5a and 6 ). Each element of Figure 6a is the coefficient of variance of the four unfiltered replicate data that correspond to the element of the matrix C having the same matrix coordinates. Figures 5a and 6a demonstrate the high variance of the replicate data corresponding to the elements of C filtered by f 4 , and the low variance of those that are not. Whereas only 16/1671 f 4 -resistant elements of C have coefficients of variance 50.7, 1049/1512 elements filtered by f 4 (green, Figure 5a ) have coefficients of vaiance 50.7 (red, Figure 6a ). The expression patterns and identities of the gene vectors that project at higher than the 99% confidence level are presented in Figure  7 .
Classes of genetic expression in gliomas
The World Health Organization's classification of brain tumors groups St. Anne -Mayo grades II and III tumors as anaplastic gliomas (WHO grade III). Our tumor set contains 13 anaplastic gliomas (samples 4 - Figure 5a reveals classes of genes that are up-and down-regulated in anaplastic gliomas and GBM as compared to normal brain. The question arose whether one could identify genes important for tumorigenesis whose expression levels differ between anaplastic gliomas and GBM. To address this question and to capture all information in the expression data of the four replicate spots, the prefiltered replicate ratios corresponding to the f 4 -resistant elements of C are compared between tumor samples 4 -16 and 17 -32 by a two-sample t-test. Mean expression levels and P values are shown in Figure 5a . ID and Name refer to clone ID and name, respectively. Columns A and B refer to mean log 2 expression values in tumor samples 4 -16 and 17 -32, respectively. P is the P-value associated with the two-sample t-test
Genetic analysis
The results identify genetic expression classes that differ between anaplastic gliomas and glioblastomas and putative oncogenes and tumor suppressor genes in glial tumors. This discovery is possible because the experimental design of four replicate spots/gene combined with mathematical modeling assign a high degree of certainty that the measured changes in gene expression are true. Patterns of genetic expression appear to divide the 92-gene set into three groups. Class I includes genes downregulated in tumors as compared to normal brain. Expression levels of genes important for oligodendrocytes differentiation namely, myelin basic protein (MBP), proteolipid proteins (PLP), and protein tyrosine phosphatases (PTP), are downregulated in 2/3 low-grade, 11/13 anaplastic tumors and 14/17 GBM (Figure 5a , class Ia). Using in situ hybridization, Landry et al. (1997) have reported that low expression of mRNAs for the two major myelin protein genes, PLP and MBP, could be used to predict the grade and extent of tumor infiltration in astrocytomas. Because the expression patterns of MBP, PLP, and PTP are tightly linked together to those of ESTs within a subclass identified by the clustering of the gene vectors (class Ia, Figure 5a ), we hypothesize that the ESTs in class Ia play a role in oligodendrocyte differentiation. Neuronal proteins and tumor suppressor genes are also down-regulated in the tumor set (class Ib). The latter includes neuronal proteins tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein (YWHAH), n-chimaerin (CHN1), synaptosomal-associated protein (SNAP-25), synaptotagmin I (SYT1), monoamine oxidase (MAO), calmodulin (CALM) I and II, and myocyte-specific enhancer- binding factor 2 (MEF2), the reticulon gene family (RTN1 and RTN3), peroxisomal matrix proteins (PEX1), beta tubulin (TUBB5), neuronal pentraxin (NPTX1), synapsin 1 (SYN1), pyruvate dehydrogenase phosphatase (PDP1), brain-specific Na-dependent inorganic phosphate co-transporter (DNP1), inositol triphosphate receptor (ITPR1), G-protein-coupled receptor (GPR51), G protein signaling regulator 4 (RGS4), neurofilament (NEFL1), neurofilament triplet L protein (NEFL), human glutamate transporter EAAT2 (SCL1A2), stathmin (LAP18), SH3-containing Grb2-like (SH3GL2), and paternally expressed gene 3 (PEG3). Deletions from the short arm of chromosome 8 (8p) including the locus of the NEFL genes are frequent in many human cancers including breast, colon, prostate, bladder, colon, and hepatocellular carcinoma (Yaremko et al., 1996; Vocke et al., 1996; Imbert et al., 1996; Kagan et al., 1995; Kerangueven et al., 1995; Lerebours et al., 1999a,b; Becker et al., 1996) . A loss of a tumor suppressor gene in that locus is thought to lead to dedifferentiation and invasive behavior of tumors. Both Dunlop et al. (1999) and Munch et al. (2001) demonstrated by RT -PCR a loss of EAAT2 in astrocytomas. RGS4 may function as a tumor suppressor gene by preventing G protein activation by platelet-activating factor receptor (Richardson et al., 2001) . Also, PEG3 and SH3GL2 are thought to have tumor suppressor gene functions. PEG3 (19q13.4) , induced by p53-mediated cell death processes, facilitates apoptosis by inducing translocation of Bax from cytosol to mitochondria. Furthermore, loss of heterogeneity of chromosome 19q is frequent in gliomas, and transfection of PEG3 cDNA into a glioma cell line abrogates tumorigenicity in nude mice (Deng and Wu, 2000; von Deimling et al., 1992; Kohda et al., 2001) . Members of the SH3GL2 family are believed to couple signals from receptors and cytoplasmic tyrosine kinases to the Ras signaling pathway (Feng et al., 1996) . TU3a (3p21.1) is a putative tumor suppressor gene located on the short arm of chromosome 3, a region commonly deleted in kidney, lung, breast, ovary, uterine, and head and neck Figure 7 Expression matrix of the clones that project at distances that correspond to higher than the 99% confidence level. Tumor columns are the same as in Figure 5a . The gene row vectors are grouped by agglomerative hierarchical clustering using single linkage and their order re-arranged following their clusters. IMAGE Ids and clone names can be viewed in supplementary information cancers (Yamato et al., 1999) . The question arises whether other ESTs or 'neuronal' protein families in class Ib have tumor suppressor functions.
Class II includes genes upregulated primarily in anaplastic tumors but significantly less so in GBM. Whereas hemoglobin alpha 1, epsilon 1 (11p15.5), and beta (11p15.5) are up-regulated in more than 50% of anaplastic tumors, they are unchanged or downregulated in more than 70% of GBM. Bianchi et al. (1991) reported complete loss of heterozygosity at the b-globin locus in 75% of mouse skin cancer. Furthermore, this is only detected in late-stage lesions exhibiting areas of dysplasia and microinvasion. The authors postulated the presence of a putative tumor suppressor gene linked to the b-globin locus. Sialyltransferases (ST3GALVI) promote neuroblastoma growth and are correlated with tumor progression in non-small cell lung cancer (Hildebrandt et al., 1998; Tanaka et al., 2000) . The ubiquitin-proteasome has been correlated to malignant transformation by a variety of pathways including different sensitivities of isoforms of p53, p27, and c-Jun to degradation (Ciechanover, 1998) . The proteasome 26s (PSMD1) is significantly up-regulated in anaplastic gliomas (P50.01). The results of Aoyama et al. (1993) (using Western blot) are similar to our findings that the lowmolecular-weight heat shock protein crystalline alpha B (CRYAB) is upregulated in 70% of anaplastic tumors but not in most GBM. The ubiquitin carboxyl-terminal hydroxylase TRE-2 (TL132) is an oncogene widely expressed in human cancer cells but not in human cells from normal tissue (Nakamura et al., 1992) .
Class III includes genes up-regulated in both anaplastic tumors and GBM. Osteonectin (SPARC) is upregulated in more than 50% of anaplastic tumors and GBM. SPARC is a secreted glycoprotein widely distributed in tissues undergoing remodeling, morphogenesis, migration and proliferation. It interacts with extracellular matrix components, regulates matrix metalloproteinase expression, and stimulates angiogenesis. It is associated with neoplastic progression of human breast, colorectal cancers, and melanoma. Furthermore, down-regulation of SPARC by antisense RNA abrogates tumorigenicity of human melanoma cells (Sage, 1997; Ledda et al., 1997; Bellahcene and Castronovo, 1995; Porte et al., 1995) . Osteopontin (SPP1) is found in all body fluids and in the proteinaceous matrix of mineralized tissue. It functions as a cell attachment protein and as a cytokine delivering signals by interacting with a number of receptors including integrins and CD44. Elevated osteopontin expression occurs in breast cancer, esophageal adenocarcinoma, and is positively correlated with tumor progression and worse prognosis in human lung adenocarcinoma and gastric tumors. The results of Saitoh et al using Northern blots and immunofluorescence are similar to our findings showing significant up-regulation of osteopontin in GBM (P50.01) (Denhardt et al., 2001; Casson et al., 1997; Ue et al., 1998; Saitoh et al., 1995) .
The elevated expression of MHC class I, (HLA-A, HLA-B, HLA-DPB1) and MHC class II (CD74) molecules (P50.01), may be caused by tumor infiltrating lymphocytes. Components of the brain extracellular matrix including vimentin, fibronectin, and laminin are synthesized and secreted by astrocytes during development.
Vimentin, previously reported by immunohistochemical analysis to be overexpressed in glial tumors, is an indicator of dedifferentiation and poor prognosis (P50.01) (Yang et al., 1994) . Fibronectin (FN1), a ligand for the integrin a5b1 promotes angiogenesis and tumor progression (Kim et al., 2000) . Kochi et al. (1983) and Higushi et al. (1993) have shown fibronectin immunoreactivity in the blood vessels of proliferating gliomas. Our results correlate fibronectin up-regulation with progression to a higher malignant phenotype (P50.01). Laminins have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis (Muir et al., 1996) . Figure 5a shows that Laminin 3 (LAMA3) is overexpressed in high-grade gliomas, but laminin receptor 1 (LAMR1) is down-regulated in most GBM. The transcript of insulin growth factor-like binding protein (IGFB7; mac25) is initially cloned from leptomeningeal epithelial cells. Mac25 expression is up-regulated in senescent human mammary epithelial cells and by treatment with retinoic acid, but is downregulated in breast carcinoma (Swisshelm et al., 1995) . Paradoxically, our results show that mac25 is upregulated in anaplastic tumors and significantly more so in GBM (P50.01) Tropomyosin (TPM1) isoforms form a family of rod-shaped proteins that bind to actin and are important for morphogenesis, neural differentiation, plasticity and formation of neuronal growth cones (Stamm et al., 1993; Schevzov et al., 1997) . The human Y-box binding proteins, YB-1, are transcription factors that are involved in a wide variety of biological functions including DNA repair, cell transcription, tumor resistance to cis-platinum, and interaction with p53 and large T antigen. YB-1 are overexpressed in almost all human colorectal cancerous lesions (Shibao et al., 1999; Okamoto et al., 2000; Ise et al., 1999; Safak et al., 1999) . Poly(A)-specific ribonucleases (PAN) degrade mRNA by targeting its poly(A) sequence; in yeast, PAN2 is required for this polyadenylation (Boeck et al., 2001 ). The results above implicate the ESTs of class III in oncogenesis and dedifferentiation to the malignant phenotype.
Analysis of ESTs sequence homology reveals that clone 491169, a member of class 1, is 100% homologous to human putative RNA-binding protein 8 (RBM8). Members of this highly-conserved family bind to OVCA1, a candidate breast and ovarian suppressor gene (Salicioni et al., 2000) . Clone 26189, is 51% homologous to the human microsomal dipeptidase precursor (MDP1) which is identical to the ubiquitin -protein ligase gene (RSP5) (Zoladek et al., 1997) . MDPI, a DNA-binding protein, inhibits the rapid growth of E-Coli and mycobacterium smegmatis, supporting the idea that it may function as a tumor suppressor gene (Matsumoto et al., 2000) . In addition, RSP5 interacts with E6-AP ubiquitin -protein ligase that binds and targets the p53 tumor-suppressor protein for ubiquitin-mediated proteolysis (Huibregtse et al., 1995) . Clone 141698, a member of class II, is 41% homologous to human oxysterol-binding protein (OXYB). The mRNA levels of the HLM gene that bears homology to OXYB are increased in circulating tumor cells in patients' peripheral blood and in primary human epithelial cells expressing the human papillomavirus 16 E6 and E7 proteins. Furthermore, HLM while undetected in normal human cells is upregulated in breast and lung cancer (Fournier et al., 1999) . Clone 30139 is similar to, and belongs to, the same expression class as myelin proteolipid protein.
Clone 27108 (Class 1) is 72% similar to mouse transcription factor regulatory protein BACH2; the latter is a member of the Maf family of basic region leucine zipper proteins that can function as transcriptional activators or repressors. Bach2 expression is restricted to monocytes and neuronal cells (Oyake et al., 1996) . Clone 162646, up-regulated in GBM, is homologous to the Ana/VASP protein family that is implicated to be involved in the control of cell motility through actin filament assembly of their GP5 motifs (Ohta et al., 1997) . Members of this family are upregulated during seizures and long-term potentiation (Kato et al., 1997) . Clone 280244 (Class 1b) is 54% similar to testican, a putative extracellular heparan/ chondroitin sulfate proteoglycan expressed in a variety of human tissues but is most abundant in brain (Marr et al., 2000) . Using subtractive hybridization, Genini et al. (1996) identified testican as highly down-regulated in an embryonal-rhabdomyosarcoma cell line as compared to human primary myobasts.
The genetic information showing up-regulation of oncogenes, chemotherapy-resistance molecules, genes that modulate the extracellular matrix and promote angiogenesis, and loss of tumor suppressor genes are all consistent with the aggressive clinical course of GBM and its bad prognosis. The validity of the extracted measurements is confirmed independently by what other investigators have reported on the expression levels of the known extracted genes in gliomas and in other tumor types using methods for molecular expression other than microarray gene profiling. In addition, we have applied real-time RT -PCR to validate the down regulation of calmodulin and tubulin beta 5-chain in five anaplastic glioma and seven GBM samples as compared to normal brain (Figure 6b ).
In brief, we report the results of expression profiling of 19 200 cDNAs in 35 human gliomas after combining four replicate measurements and modeling of false data to study the behavior of noise and devise filters to separate true from false to a high degree of confidence. Expression patterns of genes, extracted at 499.8% confidence level, generate a molecular classification that differentiates glioblastoma from lower-grade tumors and radiation necrosis. In addition, because all tumor samples are compared to RNA extracted from normal brain, the results generate a genetic analysis of gliomas. The findings identify classes of genetic expression that link novel genes to the biology of gliomas and putative functional pathways.
Materials and methods

Microarray experiments
All total tumor RNA samples are analysed in reference to a single standard obtained by pooling RNA from human occipital lobes (reference RNA). The latter are harvested and pooled from four individuals with no known neurological disease whose brains are frozen less than 3 h postmortem. Each set of 19 K microarray consists of two glass slides containing a total of 38 400 spots representing 19 200 genes laid in duplicates (19 200 spots/slide). Patients signed informed consents approved by the Institutional Review Boards. Tumor samples are frozen in liquid nitrogen in the operating room. The quality of RNA is assayed by gel electrophoresis; only high quality reference and sample RNAs are processed. Total RNA (5 -10 mg) is reverse transcribed and the cDNA products labeled by the amino -allyl method and hybridized to 19 K gene microarrays purchased from the Ontario Cancer Institute (Toronto, CA, USA). The slides include positive control spots containing Arabidopsis cDNA; in addition, 1 ng of Arabidopsis RNA transcribed in vitro is added to tumor and reference RNA. Each slide also contains negative control spots containing buffer only. The slides are scanned at 10 mm by a confocal scanner, (4000XL scanner, Perkin Elmer, Shelton, CT, USA). Images are analysed by the Imagene Software (Biodiscovery; Los Angeles, CA, USA).
Analysis of replicate data
Mathematical computing is performed using functions written in Matlab (Mathworks, Natick, MA, USA; supplementary information). Total RNA from each sample is examined by two replicate experiments where the Cy3 and Cy5 probes are switched between samples and reference (sample Cy3/reference Cy5 and sample Cy5/reference Cy3). Because the cDNAs are laid in duplicate spots, this experimental design generates four replicate data points per gene. The data are 'prepared' to calculate the background-subtracted mean intensities, and the log2 values of the corresponding normalized samples to reference ratios. The 'prep' function: (1) subtracts the local background from the intensity, (2) excludes spots that show artifactual fluorescence by visual inspection, (3) normalizes the data, (4) truncates outliers to a maximum of 50-folds change, (5) calculates and log2 transforms the normalized expression ratio of sample/reference, (6) excludes spots whose intensity measurements are within two standard deviations of the background. Spots are excluded by transforming their log2 measurement to 0. Log2 values that are positive, negative, or equal to 0 imply up-and down-regulation, or no change in gene expression as compared to normal brain, respectively.
Real time RT -PCR
Total RNA samples are analysed by one-step hot-start realtime RT -PCR (Qiagen, Valencia, CA, USA; Cepheid Smart Cycler, Sunnyvale, CA, USA). Primer pairs are generated for each gene (supplementary information). Titrated amounts of normal brain total RNA (configured as standard) and 0.5 mg of tumor total RNA samples (configured as unknown, Cepheid Smart Cycler software) are assayed with each primer pair using SYBR green. Threshold cycles are computed as the maximum of the second differentials, and plotted against the log10 of the mass of normal brain total RNA. The plotted data fit linear curves whose equations permit computing the mass of normal brain RNA equivalent to 0.5 mg of tumor RNA for a specific gene (Cepheid software). Expression ratios normalized to G3PDH are:
Computed mass of normal brain RNA for gene X Computed mass of normal brain RNA for G3PDH ð1Þ
